LABORATORIO REIG JOFRE, S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.49 EUR | -0.80% |
|
-1.19% | +10.67% |
| Mar. 13 | Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024 | |
| Feb. 29 | Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Laboratorio Reig Jofre, S.A.
413823fefec448.7dNQCbqGqMnWUwvKwO03TFNdpwgIF-BMjCMS3bZv-Y0.vv5mbcv2__2kOH2pkYkBHz48ljldQIQ551tUpIErlPfcoiVF--Dl_5IjOw~293c79945fbb98906b3fd976091d80e2
Upcoming events on Laboratorio Reig Jofre, S.A.
Past events on Laboratorio Reig Jofre, S.A.
| 2024-04-11 05:00 am | Extraordinary Shareholders Meeting - Second Call |
| 2024-04-10 05:00 am | Extraordinary Shareholders Meeting - First Call |
| 2024-03-13 04:30 am | Q4 2023 Earnings Call |
| 2024-02-28 | Q4 2023 Earnings Release Pre-market |
| 2023-10-29 | Q3 2023 Earnings Release Pre-market |
| 2023-07-26 | Q2 2023 Earnings Release |
| 2023-05-04 | Ex-dividend day for Cash amount paid with the scrip issue offered as an alternative to the dividend |
| 2023-03-31 05:00 am | Extraordinary Shareholders Meeting - Second Call |
| 2023-03-30 05:00 am | Extraordinary Shareholders Meeting - First Call |
| 2023-03-07 04:00 am | Q4 2022 Earnings Call |
| 2023-02-27 | Q4 2022 Earnings Release |
| 2022-10-27 | Q3 2022 Earnings Release |
| 2022-07-25 | Interim 2022 Earnings Release |
| 2022-06-14 | Ex-dividend day for Cash amount paid with the scrip issue offered as an alternative to the dividend |
| 2022-02-27 | FY 2021 Earnings Release Pre-market |
| 2021-10-28 | Q3 2021 Earnings Release Pre-market |
| 2021-07-28 | Interim 2021 Earnings Release Pre-market |
| 2021-04-29 05:00 am | Extraordinary Shareholders Meeting |
| 2021-04-28 | Q1 2021 Earnings Release Pre-market |
| 2021-03-05 04:00 am | FY 2020 Earnings Call |
Past dividends on Laboratorio Reig Jofre, S.A.
| 2023-05-04 | 0.0324 EUR |
| 2022-06-14 | 0.0324 EUR |
| 2021-06-09 | 0.03645 EUR |
| 2020-09-15 | 0.03159 EUR |
| 2019-05-06 | 0.03645 EUR |
| 2018-06-13 | 0.03726 EUR |
| 2017-06-15 | 0.03807 EUR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 200 203 -1.38% | 0,00 | 236 230 2.71% | 271 264 2.71% | 316 324 -2.44% |
|
EBITDA Million EUR | Released Forecast Spread | 19,7 20,9 -5.74% | 0,00 | 27,3 22,0 24.3% | 29,6 26,0 13.83% | 33,7 35,0 -3.84% |
|
EBIT Million EUR | Released Forecast Spread | 6,32 8,60 -26.48% | 0,00 | 8,86 11,0 -19.43% | 8,53 13,0 -34.37% | 10,5 15,0 -29.93% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 5,30 7,60 -30.22% | 0,00 | 5,79 8,00 -27.59% | 8,76 7,00 25.2% | 10,5 16,0 -34.4% |
|
Net income Million EUR | Released Forecast Spread | 4,94 6,70 -26.24% | 5,67 | 5,09 6,00 -15.13% | 8,11 5,00 62.14% | 9,41 13,0 -27.64% |
|
EPS EUR | Released Forecast Spread | 0,07 0,09 -22.22% | 0,08 | 0,07 0,08 -12.5% | 0,10 0,07 42.86% | 0,12 0,17 -29.41% |
| Announcement Date | 02/03/20 | 26/02/21 | 28/02/22 | 28/02/23 | 29/02/24 |
| Today 04:05 pm | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| Today 04:05 pm | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-01 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 2024-05-01 | AMGEN INC.: Q1 2024 Earnings Release |
| 2024-05-02 01:30 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:30 am | ORGANON & CO.: Q1 2024 Earnings Release |
| 2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 2024-05-02 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
Past sector events for Laboratorio Reig Jofre, S.A.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RJF Stock
- Calendar Laboratorio Reig Jofre, S.A.
